Skip to main content Accessibility help
×
Home

Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone

  • Ka-Chun Wong (a1), Wai-Yin Pang (a1), Xin-Lun Wang (a2) (a3), Sao-Keng Mok (a1), Wan-Ping Lai (a1), Hung-Kay Chow (a4), Ping-Chung Leung (a5), Xin-Sheng Yao (a3) (a6) and Man-Sau Wong (a1) (a7)...

Abstract

Drynaria fortunei (Kunze) J. Sm. (DF), a Chinese herb commonly used for the treatment of bone fracture, was previously shown to exert anabolic effects on bone. However, its active ingredients as well as the mechanisms of action are far from clear. The present study aimed to characterise the bone anabolic effects of DF flavonoid fraction (DFTF) in ovariectomised (OVX) mice and to determine if DFTF and its isolated compounds exert oestrogen-like effects in rat osteoblast-like UMR-106 cells. Young OVX C57/BL6J mice were treated orally with DFTF (0·087, 0·173 or 0·346 mg/g per d), 17β-oestradiol (2 μg/g per d) or its vehicle for 6 weeks. Serum and urine samples were collected for biochemical marker analysis. Bones were collected for computed tomography analysis. UMR-106 cells were treated with DFTF and isolated compounds naringin, (2S)-5,7,3′,5′-tetrahydroxy-flavonone 7-O-neohesperidoside (compound 1) and 5,7-dihydroxychromone 7-O-neohesperidoside (compound 2). DFTF exerted dose-dependent effects in improving bone mineral densities as well as bone strength at the femur, tibia and lumbar spine L1 in OVX mice. DFTF and the three isolated compounds stimulated osteoblastic cell proliferation and alkaline phosphatase activities in a dose-dependent manner. In addition, they stimulated the ratio of osteoprotegrin and receptor-activator NF-κB ligand mRNA expression, suggesting their involvement in inhibiting osteoclastogenesis. These stimulatory effects on osteoblastic functions were abolished in the presence of oestrogen receptor (ER) antagonist, ICI 182780. The present results suggested that DFTF is effective in protecting against OVX-induced bone loss in mice, and its actions in regulating osteoblastic activities appear to be mediated by ER.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone
      Available formats
      ×

Copyright

Corresponding author

*Corresponding authors: Dr M.-S. Wong, fax +852 23649932, email bcmswong@polyu.edu.hk; X.-S. Yao, email tyaoxs@jun.edu.cn

References

Hide All
1Banu, J, Varela, E & Fernandes, G (2012) Alternative therapies for the prevention and treatment of osteoporosis. Nutr Rev 70, 2240.
2Khosla, S (2010) Update on estrogens and the skeleton. J Clin Endocrinol Metab 95, 35693577.
3Al-Anazi, AF, Qureshi, VF, Javaid, K, et al. (2011) Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: an overview. J Nat Sci Biol Med 2, 154163.
4Gass, M & Dawson-Hughes, B (2006) Preventing osteoporosis-related fractures: an overview. Am J Med 119, S3S11.
5Cassidy, A (2003) Dietary phytoestrogens and bone health. J Br Menopause Soc 9, 1721.
6Zhang, Y, Chen, WF, Lai, WP, et al. (2008) Soy isoflavones and their bone protective effects. Inflammopharmacology 16, 213215.
7Zhang, Y, Li, Q, Wan, HY, et al. (2009) Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice. J Nutr 139, 22302236.
8Lampe, JW (2003) Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 133, Suppl. 3, 956S964S.
9Mok, SK, Chen, WF, Lai, WP, et al. (2010) Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol 159, 939949.
10Pang, WY, Wang, XL, Mok, SK, et al. (2010) Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. Br J Pharmacol 159, 16931703.
11Mei, J, Yeung, SSC & Kung, AWC (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86, 52175221.
12Zhang, Y, Li, Q, Li, X, et al. (2010) Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. Br J Nutr 104, 965971.
13Chen, WF, Mok, SK, Wang, XL, et al. (2011) Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. Br J Nutr 105, 180189.
14Zhang, Y, Li, Q, Wan, HY, et al. (2011) Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. Osteoporos Int 22, 703709.
15Zhou, Q (2003) Clinical application of Drynaria in orthopedics and traumatology. J Tradit Chin Orthop Traumatol 15, 59.
16Sun, JS, Dong, GC, Lin, CY, et al. (2003) The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) immobilized modified calcium hydrogenphosphate on bone cell activities. Biomaterials 24, 873882.
17Jeong, JC, Lee, JW, Yoon, CH, et al. (2004) Drynariae rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1. Toxicol In Vitro 18, 829834.
18Jeong, JC, Lee, JW, Yoon, CH, et al. (2005) Stimulative effects of Drynariae rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells. J Ethnopharmacol 96, 489495.
19Jeong, JCLB, Yoon, CH, Kim, HM, et al. (2005) Effects of Drynariae rhizoma on the proliferation of human bone cells and the immunomodulatory activity. Pharm Res 51, 125136.
20Wong, RW & Rabie, AB (2006) Systemic effect of crude extract from rhizome of Drynaria fortunei on bone formation in mice. Phytother Res 20, 313315.
21Wong, RW, Rabie, B, Bendeus, M, et al. (2007) The effects of rhizoma Curculiginis and rhizoma Drynariae extracts on bones. Chin Med 2, 13.
22Sun, JHW & Liu, K (2008) The research of Drynaria total flavonoids and osteoporosis research. Chin J Osteo 14, 763766.
23Chen, LLLL, Ding, PH, Tang, Q, et al. (2011) Osteogenic effect of Drynariae rhizome extracts and naringin on MC3T3-E1 cells and an induced rat alveolar bone resorption model. Arch Oral Biol 56, 16551662.
24Guo, D, Wang, J, Wang, X, et al. (2011) Double directional adjusting estrogenic effect of naringin from rhizoma Drynariae (Gusuibu). J Ethnopharmacol 138, 451457.
25Jeong, JC, Kang, SK, Youn, CH, et al. (2003) Inhibition of Drynariae rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts. Int Immunopharmacol 3, 16851697.
26Wang, XL, Wang, NL, Zhang, Y, et al. (2008) Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (KUNZE) J. SM. on osteoblastic proliferation using an osteoblast-like cell line. Chem Pharm Bull (Tokyo) 56, 4651.
27Eun Ju Chang WJL, Sung Hee Cho, Sang Won Choi. (2003) Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of Drynaria fortunei on MCF-7 and osteoblastic cells. Arch Pharm Res 26, 620–630.
28Wang, XL, Wang, NL, Gao, H, et al. (2010) Phenylpropanoid and flavonoids from osteoprotective fraction of Drynaria fortunei. Nat Prod Res 24, 12061213.
29Wang, X, Zhen, L, Zhang, G, et al. (2011) Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei – an in vitro efficacy study. Phytomedicine 18, 868872.
30Wang, XLWN, Wong, MS & Yao, XS (2008) Phenylpropanoid compounds isolated from Drynaria fortunei and their proliferation effects on UMR 106 cells. J Shenyang Pharm Univ 25, 2429.
31Lu, Y, Zhang, C, Bucheli, P, et al. (2006) Citrus flavonoids in fruit and traditional Chinese medicinal food ingredients in China. Plant Foods Hum Nutr 61, 5765.
32Wei, M, Yang, Z, Li, P, et al. (2007) Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am J Chin Med 35, 663667.
33Mandadi, K, Ramirez, M, Jayaprakasha, GK, et al. (2009) Citrus bioactive compounds improve bone quality and plasma antioxidant activity in orchidectomized rats. Phytomedicine 16, 513520.
34Wu, JB, Fong, YC, Tsai, HY, et al. (2008) Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 588, 333341.
35Li, L, Zeng, Z & Cai, G (2011) Comparison of neoeriocitrin and naringin on proliferation and osteogenic differentiation in MC3T3-E1. Phytomedicine 18, 985989.
36Xie, F, Wu, CF, Lai, WP, et al. (2005) The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. Evid Based Complement Alternat Med 2, 353361.
37Wong, RW & Rabie, AB (2006) Effect of naringin on bone cells. J Orthop Res 24, 20452050.
38Chang, EJ, Lee, WJ, Cho, SH, et al. (2003) Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of Drynaria fortunei on MCF-7 and osteoblastic cells. Arch Pharm Res 26, 620630.
39Kosuge, K, Mitsunaga, K, Koike, K, et al. (1994) Studies on the constituents of Ailanthus integrifolia. Chem Pharm Bull (Tokyo) 42, 16691671.
40Gasser, JA & Willnecker, J (2012) Bone measurements by peripheral quantitative computed tomography in rodents. Methods Mol Biol 816, 477498.
41Zhang, Y, Leung, PC, Che, CT, et al. (2008) Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus Ligustri Lucidi. Br J Nutr 99, 494502.
42Lau, WS, Chan, RY, Guo, DA, et al. (2008) Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway. J Steroid Biochem Mol Biol 108, 6471.
43Xie, Y-M, Xu, Y-G, Zhao, J-N, et al. (2004) Effect of osteopractic total flavone on density of bones of rats without ovaria and levels. China J Basic Med Tradit Chin Med 10, 3437.
44Zhang, J, Li, HP, Yang, PL, et al. (2009) Effects of total flavonoids from rhizoma Drynariae medicated serum on proliferation, differentiation, cell cycle and apoptosis of osteoblasts in vitro. Zhong Yao Cai 32, 10901093.
45Pang, WYWX, Mok, SK, Lai, WP, et al. (2010) Naringin activates estrogen receptor ligand-independently in rat osteoblast-like (UMR 106) cells and improves bone properties in ovariectomized mice. Br J Pharmacol 159, 16931703.
46Bord, S, Ireland, DC, Beavan, SR, et al. (2003) The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32, 136141.
47Chen, XW, Garner, SC & Anderson, JJ (2002) Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochem Biophys Res Commun 295, 417422.
48Zhu, H, Wang, WJ & Wang, ZM (2010) Effects of Drynariae rhizoma total flavone on Smad1 Smad5 mRNA expression in osteoporosis. Chin Arch Trad Chin Med 28, 200204.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed